Regulation
-
Push to accelerate electronic prior authorization adoption gains momentum
Twenty-nine healthcare organizations have joined CMS in a national effort to streamline electronic prior authorization before new federal requirements take effect in 2027.
-
UK government moves on ticket touting draw lukewarm response
Live industry figures dismayed by lack of progress, while online platforms face uncertainty over compliance.
-
HHS secretary directs wide‑ranging federal vaccine review
Multi-agency vaccine safety review prompts pushback from former CDC officials and researchers for revisiting issues already extensively studied.
-
ACER’s 2026 REMIT Surveillance Report: Strengthening EU energy market oversight
ACER backs NRA enforcement of REMIT and demands better surveillance from traders.
-
Health Canada seeks input on new drug review process
Proposed framework would allow Canadian regulator to use drug approval decisions from foreign agencies to speed up approvals in Canada.
-
Optum Rx launches ‘transparent,’ fee‑based pharmacy benefit model
The PBM’s announcement model comes amid growing pressure on the nation’s largest pharmacy benefit managers to abandon opaque pricing structures and comply with expanding federal and state transparency requirements.
-
Medicare to offer $50 monthly access to GLP‑1 drugs under new CMS demonstration
Part D enrollees will gain $50 monthly access to select GLP-1 medications through a new CMS demonstration program – but at what price?
-
FDA Commissioner Marty Makary out following policy dispute
Makary stepped down amid a widening rift over tobacco regulation and a series of contentious decisions that reshaped the FDA’s internal politics.